Review



biotinylated goat anti human α syn antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems biotinylated goat anti human α syn antibody
    Scatter plots of cerebrospinal <t>fluid</t> <t>α-synuclein</t> concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive
    Biotinylated Goat Anti Human α Syn Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+goat+anti+human+%CE%B1+syn+antibody/Human+alpha-Synuclein+Biotinylated+Antibody/pmc07685645-84-24-29
    Average 94 stars, based on 8 article reviews
    biotinylated goat anti human α syn antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders"

    Article Title: Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders

    Journal: Translational Neurodegeneration

    doi: 10.1186/s40035-020-00222-1

    Scatter plots of cerebrospinal fluid α-synuclein concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive
    Figure Legend Snippet: Scatter plots of cerebrospinal fluid α-synuclein concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive

    Techniques Used: Diagnostic Assay, Concentration Assay

    Associations between CSF α-synuclein and longitudinal neuroimaging change in ADNI. Data from linear mixed-effects models (left) and cox proportional hazards models (right) were adjusted for age, gender, educational level and APOE ε4 genotype. Hippocampal volume on the y axis was log-transformed to ensure normality. Time (years) on the x axis indicated follow-up years, in which “0” indicating the baseline. All participants were classified into High and Low groups according to their baseline CSF α-synuclein concentration (High: greater than median; Low: less than median)
    Figure Legend Snippet: Associations between CSF α-synuclein and longitudinal neuroimaging change in ADNI. Data from linear mixed-effects models (left) and cox proportional hazards models (right) were adjusted for age, gender, educational level and APOE ε4 genotype. Hippocampal volume on the y axis was log-transformed to ensure normality. Time (years) on the x axis indicated follow-up years, in which “0” indicating the baseline. All participants were classified into High and Low groups according to their baseline CSF α-synuclein concentration (High: greater than median; Low: less than median)

    Techniques Used: Transformation Assay, Concentration Assay

    Related Articles

    Clinical Proteomics:

    Article Title: Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
    Article Snippet: The plasma NFL concentrations were measured using an NFL kit (NF-light; Uman Diagnostics), transferred onto the ultrasensitive single-molecule array platform using a home brew kit (Simoa Homebrew Assay Development Kit; Quanterix Corporation). .. The levels of CSF total α-synuclein concentrations in the ADNI cohort were measured by the Luminex MicroPlex Microspheres (Luminex Corp, Austin, TX), using the biotinylated goat anti-human α-syn antibody (R&D systems, Minneapolis, MN) as the detection antibody. .. The α-synuclein Luminex assay demonstrated a low day-to-day and plate-to-plate signal variety.



    Similar Products

    biotinylated goat anti human α syn antibody  (R&D Systems)
    94
    R&D Systems biotinylated goat anti human α syn antibody
    Scatter plots of cerebrospinal <t>fluid</t> <t>α-synuclein</t> concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive
    Biotinylated Goat Anti Human α Syn Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+goat+anti+human+%CE%B1+syn+antibody/Human+alpha-Synuclein+Biotinylated+Antibody/pmc07685645-84-24-29
    Average 94 stars, based on 1 article reviews
    biotinylated goat anti human α syn antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    biotinylated goat polyclonal anti-α-syn (raised against full-length recombinant human α-syn  (R&D Systems)
    90
    R&D Systems biotinylated goat polyclonal anti-α-syn (raised against full-length recombinant human α-syn
    Scatter plots of cerebrospinal <t>fluid</t> <t>α-synuclein</t> concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive
    Biotinylated Goat Polyclonal Anti α Syn (Raised Against Full Length Recombinant Human α Syn, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biotinylated+goat+anti+human+%CE%B1+syn+antibody/Normal+Goat+IgG+Biotinylated+Control/pmc04271448-69-5-17
    Average 90 stars, based on 1 article reviews
    biotinylated goat polyclonal anti-α-syn (raised against full-length recombinant human α-syn - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Scatter plots of cerebrospinal fluid α-synuclein concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive

    Journal: Translational Neurodegeneration

    Article Title: Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders

    doi: 10.1186/s40035-020-00222-1

    Figure Lengend Snippet: Scatter plots of cerebrospinal fluid α-synuclein concentrations in the diagnostic groups. The colors of the scatterplots are grouped by different diagnostic groups. The three horizontal black lines in each boxplot indicate the median and interquartile range. The whiskers extend to the minimum and maximum CSF α-synuclein data points. a CSF α-synuclein concentration in the diagnostic groups. b CSF α-synuclein concentration in the diagnostic groups stratified by Aβ pathology. c CSF α-synuclein concentration in the AD pathophysiology (tau and amyloid-β) positive and negative subgroups. A-, Aβ negative; A+, Aβ positive; T-, tau negative; T+, tau positive

    Article Snippet: The levels of CSF total α-synuclein concentrations in the ADNI cohort were measured by the Luminex MicroPlex Microspheres (Luminex Corp, Austin, TX), using the biotinylated goat anti-human α-syn antibody (R&D systems, Minneapolis, MN) as the detection antibody.

    Techniques: Diagnostic Assay, Concentration Assay

    Associations between CSF α-synuclein and longitudinal neuroimaging change in ADNI. Data from linear mixed-effects models (left) and cox proportional hazards models (right) were adjusted for age, gender, educational level and APOE ε4 genotype. Hippocampal volume on the y axis was log-transformed to ensure normality. Time (years) on the x axis indicated follow-up years, in which “0” indicating the baseline. All participants were classified into High and Low groups according to their baseline CSF α-synuclein concentration (High: greater than median; Low: less than median)

    Journal: Translational Neurodegeneration

    Article Title: Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders

    doi: 10.1186/s40035-020-00222-1

    Figure Lengend Snippet: Associations between CSF α-synuclein and longitudinal neuroimaging change in ADNI. Data from linear mixed-effects models (left) and cox proportional hazards models (right) were adjusted for age, gender, educational level and APOE ε4 genotype. Hippocampal volume on the y axis was log-transformed to ensure normality. Time (years) on the x axis indicated follow-up years, in which “0” indicating the baseline. All participants were classified into High and Low groups according to their baseline CSF α-synuclein concentration (High: greater than median; Low: less than median)

    Article Snippet: The levels of CSF total α-synuclein concentrations in the ADNI cohort were measured by the Luminex MicroPlex Microspheres (Luminex Corp, Austin, TX), using the biotinylated goat anti-human α-syn antibody (R&D systems, Minneapolis, MN) as the detection antibody.

    Techniques: Transformation Assay, Concentration Assay